A pivotal multicenter trial evaluating efficacy and safety of the hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with advanced basal cell carcinoma Sekulic, A., Oro, A. E., Solomon, J. A., Hainsworth, J. D., Lewis, K., Dirix, L., Migden, M. R. MOSBY-ELSEVIER. 2012: AB149

View details for Web of Science ID 000302319800593